A retrospective analysis of 355 patients found that RF and anti-CCP levels, anti-Ro/SS-A positivity, and renal involvement can effectively differentiate high-risk RA-SS populations, consistent with the immunological marker profile identified in this study (27). Here, CALR is linked to synovial sarcoma.